Vaksin Arexvy GSK untuk RSV diluluskan di Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) hari ini mengumumkan bahawa vaksin Arexvy (MAL24086007ARZ) telah diluluskan di Malaysia untuk virus sinsitium pernafasan (RSV).
Tue Sep 24 2024
Ubat COVID-19: EU tandatangan perjanjian dengan GSK
Dibangunkan bersama firma Amerika Syarikat Vir Biotechnology, ubat ini boleh digunakan untuk pesakit koronavirus berisiko tinggi dengan gejala ringan, yang tidak memerlukan oksigen.
Wed Jul 28 2021
Vir, GSK's COVID-19 antibody trial shows 85 pct drop in hospitalization or death
They were planning to submit an emergency use authorization application to the U.S. Food and Drug Administration for the treatment.
Thu Mar 11 2021
Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight
Sanofi and GlaxoSmithKline said clinical trials of their COVID-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year.
Fri Dec 11 2020
China's Clover says its COVID-19 vaccines trigger "strong immune responses" in early trial
Based on positive Phase 1 results reported, Clover is confident to enter late-stage clinical development for both adjuvanted vaccines.
Fri Dec 04 2020
Next big COVID-19 treatment may be manufactured antibodies
The next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other disorders - antibodies designed specifically to attack this new virus.
Tue Aug 04 2020
China bars GSK executive from leaving amid bribery probe
Chinese authorities have barred the British finance director of GlaxoSmithKline (GSK) in China from leaving the country.
Thu Jul 18 2013